Anti-Obesity Medication. NPT VTS Teaching Programme Bethan Yeoman. Anti-Obesity Medication – General Principles. Should not be first-line in treatment of obesity Should only be used in conjunction with a healthy eating and good exercise programme.
*Rimonabant has recently been linked to a two-fold increase in psychiatric problems including suicide and the European Medicines Agency (and UK MHRA) has asked doctors not to prescribe the drug and to review all those who are currently taking it.